phenyl-n-tert-butylnitrone has been researched along with erythrosine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ames, BN; Hagen, TM; Wehr, CM | 1 |
| Aksenov, MY; Aksenova, MV; Butterfield, DA; Carney, JM; Cole Harper, P; DeAtley, SM; Hadley, R; Harris, B | 1 |
2 other study(ies) available for phenyl-n-tert-butylnitrone and erythrosine
| Article | Year |
|---|---|
Mitochondrial decay in aging. Reversal through supplementation of acetyl-L-carnitine and N-tert-butyl-alpha-phenyl-nitrone.
Topics: Acetylcarnitine; Aging; Animals; Cells, Cultured; Cyclic N-Oxides; Dietary Supplements; Fluoresceins; Injections, Intraperitoneal; Liver; Male; Mitochondria, Liver; Nitrogen Oxides; Oxidants; Oxygen Consumption; Rats; Rats, Inbred F344 | 1998 |
Antioxidants protect against reactive oxygen species associated with adriamycin-treated cardiomyocytes.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Chromans; Cyclic N-Oxides; Dose-Response Relationship, Drug; Doxorubicin; Fluoresceins; Heart; Mesalamine; Myocardium; Nitrogen Oxides; Oxidative Stress; Rats; Reactive Oxygen Species | 1999 |